(Q47752246)

5 February 2018

title

Four-year trends in Helicobacter pylori IgG serology following successful eradication (English)

1 reference

5 February 2018

0 references

1 reference

Cutler AF

1

1 reference

5 February 2018

Prasad VM

series ordinal

2

1 reference

5 February 2018

Santogade P

series ordinal

3

1 reference

5 February 2018

language of work or name

English

0 references

publication date

1 July 1998

1 reference

5 February 2018

American Journal of Medicine

published in

1 reference

5 February 2018

volume

105

1 reference

5 February 2018

issue

1

1 reference

5 February 2018

page(s)

18-20

1 reference

5 February 2018

Role of Helicobacter pylori in the pathogenesis of gastritis, peptic ulcer and gastric cancer.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900134-X

Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900134-X

Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900134-X

PROSPECTIVE DOUBLE-BLIND TRIAL OF DUODENAL ULCER RELAPSE AFTER ERADICATION OF CAMPYLOBACTER PYLORI

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900134-X

Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900134-X

Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900134-X

Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900134-X

Diagnosis of Campylobacter pylori infections: the "gold standard" and the alternatives.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900134-X

Evaluation of a commercial ELISA for serodiagnosis of Helicobacter pylori infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900134-X

Campylobacter pylori antibodies in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900134-X

Role of Helicobacter pylori serology in evaluating treatment success

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900134-X

Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900134-X

Long term serological surveillance after treatment of Helicobacter pylori infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900134-X

Antibody titres to Campylobacter pylori after treatment for gastritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900134-X

Seroconversion for Helicobacter pylori.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900134-X

Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: clinical and economic consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900134-X

Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900134-X

Campylobacter pylori infection in biopsy specimens of gastric antrum: laboratory diagnosis and estimation of sampling error

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900134-X

10.1016/S0002-9343(98)00134-X

7 January 2021

Identifiers

DOI

1 reference

5 February 2018

1 reference

5 February 2018